Physician profile
Derrick C Wan
NPI 1053513473
$4,048.18
in general payments reported to CMS, 2019-2025
8 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $126 · 2021: $420 · 2022: $350 · 2023: $936 · 2024: $1,384 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733 · Travel and Lodging: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,733.17 |
| Travel and Lodging | $220.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,013.78 | 2019-2025 | Matrixorthognathic, Na, Trumatch |
| Kls-Martin L.P. | $939.15 | 2019-2024 | |
| Musculoskeletal Transplant Foundation INC. | $430.56 | 2022-2023 | |
| Medical Device Business Services, INC. | $332.29 | 2024 | |
| Tela Bio, INC. | $138.67 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $96.01 | 2024-2025 | N/A, Echelon Flex, Echelon Circular |
| Stryker Corporation | $55.54 | 2021-2022 | |
| Smith+Nephew, INC. | $42.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Wan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.